Immune Tolerance Symposium 2018

http://diabetes.ucsf.edu/abbas-symposium

 

 

 

 

 

 

 

 

IMMUNE TOLERANCE: PRESENT AND FUTURE

IN HONOR OF ABUL K. ABBAS’ DECADES OF CONTRIBUTIONS TO IMMUNOLOGY, EDUCATION, AND PATHOLOGY

 

FridayMarch 2, 2018

8:30 a.m. - 5:00 p.m.

Genentech Hall, Mission Bay

 

Welcome & Introductions

Sam Hawgood, Chancellor, University of California San Francisco

Haile Debas, Emeritus Chancellor, University of California San Francisco

Jeff Bluestone, University of California San Francisco

 

I. Positive and Negative Signaling in Immunity

Art Weiss, UCSF – “Signaling requirements for T cells”

Lucy Walker, UCL, London – “The yin/yang of CD28 and CTLA-4 in T cell activation and tolerance”

Vijay Kuchroo, Brigham and Women’s Hospital, Harvard – “T cell subsets in autoimmunity and cancer”

 

II. T cell Subsets in Heath and Disease

Andrew Lichtman, Brigham and Women’s Hospital, Harvard – “Migration and function of Teff cells in cardiovascular diseases”

Michael Rosenblum, UCSF –“Immunoregulation in the skin – role of Tregs and IL-2”

Arlene Sharpe, Harvard – “Elucidating the functions of T cell costimulatory pathways in health and disease”

 

III. Immunity and Disease

Shiv Pillai, Mass Gen Hospital, Harvard – “B cell development and lineage commitment in patients with Chronic Lymphocytic Leukemia”

David Hafler, Yale – “Central mechanisms underlying the cause of Multiple Sclerosis”

Birgit Knoechel, DCFI, Harvard – “Metabolic mechanisms of drug resistance in leukemia”

Jeffrey Bluestone, UCSF – “Immune tolerance in autoimmunity – Exploiting Tregs and IL-2”

 

IV. Back to Basics in Immunity

Hans Dooms, Boston University – “Controlling autoimmunity through IL-7 receptor antagonism

Laurie Glimcher, DFCI, Harvard – “The unfolded protein response in cancer and autoimmunity”

Lewis Lanier, UCSF – “Memory NK cells”

Mark Anderson, UCSF – “Control of thymic selection by AIRE”

 

RECEPTION TO FOLLOW IN ATRIUM